DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
DE10041479A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US20040048779A1
(en)
*
|
2002-05-06 |
2004-03-11 |
Erwin Schollmayer |
Use of rotigotine for treating the restless leg syndrome
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
DE10261696A1
(de)
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
DE10334188B4
(de)
*
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
DE10334187A1
(de)
*
|
2003-07-26 |
2005-03-03 |
Schwarz Pharma Ag |
Substituierte 2-Aminotetraline zur Behandlung von Depressionen
|
DE10359528A1
(de)
*
|
2003-12-18 |
2005-07-28 |
Schwarz Pharma Ag |
(S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
|
DE10361258A1
(de)
*
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
|
US20050197385A1
(en)
*
|
2004-02-20 |
2005-09-08 |
Schwarz Pharma Ag |
Use of rotigotine for treatment or prevention of dopaminergic neuron loss
|
DE102004014841B4
(de)
*
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
TWI392670B
(zh)
*
|
2006-06-22 |
2013-04-11 |
Ucb Pharma Gmbh |
經取代的2-胺基萘滿之於製造用於預防、減緩及/或治療各種類型疼痛之藥物上的用途
|
EP1987815A1
(en)
*
|
2007-05-04 |
2008-11-05 |
Schwarz Pharma Ag |
Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
|
CN101970422B
(zh)
*
|
2007-11-28 |
2014-10-22 |
Ucb制药有限公司 |
罗替高汀的多晶型物
|
US8555875B2
(en)
|
2008-12-23 |
2013-10-15 |
Map Pharmaceuticals, Inc. |
Inhalation devices and related methods for administration of sedative hypnotic compounds
|
WO2010073124A2
(en)
*
|
2008-12-26 |
2010-07-01 |
Actavis Group Ptc Ehf |
Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
|
EP2201941A1
(de)
|
2008-12-29 |
2010-06-30 |
UCB Pharma GmbH |
Pflaster-Herstellungstechnologie
|
EP2281559A1
(en)
|
2009-06-26 |
2011-02-09 |
UCB Pharma GmbH |
Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
|
ME03053B
(me)
|
2009-12-22 |
2018-10-20 |
Ucb Biopharma Sprl |
Polivinilpirolidon za stabilizaciju čvrste disperzije nekristalnog oblika rotigotina
|
JP5699030B2
(ja)
*
|
2010-07-05 |
2015-04-08 |
Axis株式会社 |
エタネルセプトを含む線維筋痛症の治療剤
|
WO2013075823A1
(en)
|
2011-11-22 |
2013-05-30 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermal therapeutic system comprising rotigotine and crystallization inhibitor
|
DE102012013439A1
(de)
|
2012-07-03 |
2014-01-23 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System umfassend Rotigotin und Kristallisationsinhibitor
|
DE102012013421A1
(de)
|
2012-07-03 |
2014-01-09 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System (TTS) mit Rotigotin
|
US9707191B2
(en)
|
2013-11-05 |
2017-07-18 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11576877B2
(en)
|
2013-11-05 |
2023-02-14 |
Antecip Bioventures Ii Llc |
Bupropion as modulator of drug activity
|
US11534414B2
(en)
|
2013-11-05 |
2022-12-27 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11129826B2
(en)
|
2013-11-05 |
2021-09-28 |
Axsome Therapeutics, Inc. |
Bupropion as a modulator of drug activity
|
US11096937B2
(en)
|
2013-11-05 |
2021-08-24 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10512643B2
(en)
|
2013-11-05 |
2019-12-24 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11433067B2
(en)
|
2013-11-05 |
2022-09-06 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9700528B2
(en)
|
2013-11-05 |
2017-07-11 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11617728B2
(en)
|
2013-11-05 |
2023-04-04 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11207281B2
(en)
|
2013-11-05 |
2021-12-28 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11123343B2
(en)
|
2013-11-05 |
2021-09-21 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10894047B2
(en)
|
2013-11-05 |
2021-01-19 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11596627B2
(en)
|
2013-11-05 |
2023-03-07 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11058648B2
(en)
|
2013-11-05 |
2021-07-13 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10874663B2
(en)
|
2013-11-05 |
2020-12-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9968568B2
(en)
|
2013-11-05 |
2018-05-15 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11065248B2
(en)
|
2013-11-05 |
2021-07-20 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9198905B2
(en)
|
2013-11-05 |
2015-12-01 |
Antecip Bioventures Ii Llc |
Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects
|
US10874665B2
(en)
|
2013-11-05 |
2020-12-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10945973B2
(en)
|
2013-11-05 |
2021-03-16 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10894046B2
(en)
|
2013-11-05 |
2021-01-19 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11576909B2
(en)
|
2013-11-05 |
2023-02-14 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11234946B2
(en)
|
2013-11-05 |
2022-02-01 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10980800B2
(en)
|
2013-11-05 |
2021-04-20 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9408815B2
(en)
|
2013-11-05 |
2016-08-09 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11197839B2
(en)
|
2013-11-05 |
2021-12-14 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11969421B2
(en)
|
2013-11-05 |
2024-04-30 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9457023B1
(en)
|
2013-11-05 |
2016-10-04 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11007189B2
(en)
|
2013-11-05 |
2021-05-18 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11590124B2
(en)
|
2013-11-05 |
2023-02-28 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11439636B1
(en)
|
2013-11-05 |
2022-09-13 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11541021B2
(en)
|
2013-11-05 |
2023-01-03 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10881657B2
(en)
|
2013-11-05 |
2021-01-05 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11497721B2
(en)
|
2013-11-05 |
2022-11-15 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US20220233470A1
(en)
|
2013-11-05 |
2022-07-28 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11123344B2
(en)
|
2013-11-05 |
2021-09-21 |
Axsome Therapeutics, Inc. |
Bupropion as a modulator of drug activity
|
US11571399B2
(en)
|
2013-11-05 |
2023-02-07 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10864209B2
(en)
|
2013-11-05 |
2020-12-15 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11617747B2
(en)
|
2013-11-05 |
2023-04-04 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9763932B2
(en)
|
2013-11-05 |
2017-09-19 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US10874664B2
(en)
|
2013-11-05 |
2020-12-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11524007B2
(en)
|
2013-11-05 |
2022-12-13 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11229640B2
(en)
|
2013-11-05 |
2022-01-25 |
Antecip Bioventures Ii Llc |
Combination of dextromethorphan and bupropion for treating depression
|
US10813924B2
(en)
|
2018-03-20 |
2020-10-27 |
Antecip Bioventures Ii Llc |
Bupropion and dextromethorphan for treating nicotine addiction
|
US11478468B2
(en)
|
2013-11-05 |
2022-10-25 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11020389B2
(en)
|
2013-11-05 |
2021-06-01 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11141416B2
(en)
|
2013-11-05 |
2021-10-12 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11344544B2
(en)
|
2013-11-05 |
2022-05-31 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11419867B2
(en)
|
2013-11-05 |
2022-08-23 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11426370B2
(en)
|
2013-11-05 |
2022-08-30 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10780064B2
(en)
|
2019-01-07 |
2020-09-22 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11253492B2
(en)
|
2013-11-05 |
2022-02-22 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10933034B2
(en)
|
2013-11-05 |
2021-03-02 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11510918B2
(en)
|
2013-11-05 |
2022-11-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9474731B1
(en)
|
2013-11-05 |
2016-10-25 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11273133B2
(en)
|
2013-11-05 |
2022-03-15 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9402843B2
(en)
|
2013-11-05 |
2016-08-02 |
Antecip Bioventures Ii Llc |
Compositions and methods of using threohydroxybupropion for therapeutic purposes
|
US11311534B2
(en)
|
2013-11-05 |
2022-04-26 |
Antecip Bio Ventures Ii Llc |
Bupropion as a modulator of drug activity
|
US20160324807A1
(en)
|
2013-11-05 |
2016-11-10 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11291665B2
(en)
|
2013-11-05 |
2022-04-05 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11364233B2
(en)
|
2013-11-05 |
2022-06-21 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11291638B2
(en)
|
2013-11-05 |
2022-04-05 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10799497B2
(en)
|
2013-11-05 |
2020-10-13 |
Antecip Bioventures Ii Llc |
Combination of dextromethorphan and bupropion for treating depression
|
US10940124B2
(en)
|
2019-01-07 |
2021-03-09 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10105327B2
(en)
|
2013-11-05 |
2018-10-23 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects
|
US11357744B2
(en)
|
2013-11-05 |
2022-06-14 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US20200338022A1
(en)
|
2019-01-07 |
2020-10-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11090300B2
(en)
|
2013-11-05 |
2021-08-17 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11426401B2
(en)
|
2013-11-05 |
2022-08-30 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11541048B2
(en)
|
2013-11-05 |
2023-01-03 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10105361B2
(en)
|
2013-11-05 |
2018-10-23 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11191739B2
(en)
|
2013-11-05 |
2021-12-07 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11273134B2
(en)
|
2013-11-05 |
2022-03-15 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10772850B2
(en)
|
2013-11-05 |
2020-09-15 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10786469B2
(en)
|
2013-11-05 |
2020-09-29 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US11298352B2
(en)
|
2013-11-05 |
2022-04-12 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11285118B2
(en)
|
2013-11-05 |
2022-03-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10080727B2
(en)
|
2013-11-05 |
2018-09-25 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US20160361305A1
(en)
|
2013-11-05 |
2016-12-15 |
Antecip Bioventures Ii Llc |
Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
|
US10688066B2
(en)
|
2018-03-20 |
2020-06-23 |
Antecip Bioventures Ii Llc |
Bupropion and dextromethorphan for treating nicotine addiction
|
US11147808B2
(en)
|
2013-11-05 |
2021-10-19 |
Antecip Bioventures Ii Llc |
Method of decreasing the fluctuation index of dextromethorphan
|
US11382874B2
(en)
|
2013-11-05 |
2022-07-12 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9457025B2
(en)
|
2013-11-05 |
2016-10-04 |
Antecip Bioventures Ii Llc |
Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
|
US11213521B2
(en)
|
2013-11-05 |
2022-01-04 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9867819B2
(en)
|
2013-11-05 |
2018-01-16 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US10898453B2
(en)
|
2013-11-05 |
2021-01-26 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11571417B2
(en)
|
2013-11-05 |
2023-02-07 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11253491B2
(en)
|
2013-11-05 |
2022-02-22 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11298351B2
(en)
|
2013-11-05 |
2022-04-12 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11185515B2
(en)
|
2013-11-05 |
2021-11-30 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10966942B2
(en)
|
2019-01-07 |
2021-04-06 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9861595B2
(en)
|
2013-11-05 |
2018-01-09 |
Antecip Bioventures Ii Llc |
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
|
US10966974B2
(en)
|
2013-11-05 |
2021-04-06 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US11517543B2
(en)
|
2013-11-05 |
2022-12-06 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US10966941B2
(en)
|
2013-11-05 |
2021-04-06 |
Antecip Bioventures Ii Llp |
Bupropion as a modulator of drug activity
|
US11285146B2
(en)
|
2013-11-05 |
2022-03-29 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
US9956201B2
(en)
|
2014-07-21 |
2018-05-01 |
Spriaso Llc |
Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms
|
DE102017104026A1
(de)
*
|
2017-02-27 |
2018-08-30 |
Lts Lohmann Therapie-Systeme Ag |
Nicotin enthaltendes transparentes transdermales therapeutisches System
|
US10932711B2
(en)
|
2017-02-27 |
2021-03-02 |
Payman Sadeghi |
Method and system for neurohydrodissection
|
KR20200046461A
(ko)
*
|
2018-10-24 |
2020-05-07 |
에스케이케미칼 주식회사 |
비결정 로티고틴 함유 조성물 및 이의 제조 방법
|
US10925842B2
(en)
|
2019-01-07 |
2021-02-23 |
Antecip Bioventures Ii Llc |
Bupropion as a modulator of drug activity
|
CA3196606A1
(en)
*
|
2020-10-27 |
2022-05-05 |
Deyao LI |
Tetrahydronaphthalene compounds, pharmaceutical compositions, and uses thereof
|
US11717518B1
(en)
|
2022-06-30 |
2023-08-08 |
Antecip Bioventures Ii Llc |
Bupropion dosage forms with reduced food and alcohol dosing effects
|
US11730706B1
(en)
|
2022-07-07 |
2023-08-22 |
Antecip Bioventures Ii Llc |
Treatment of depression in certain patient populations
|